Abstract
Objective: The purpose of the current study was to evaluate the diagnostic accuracies of 18F-FDG PET or PET/CT for diagnosis of Merkel cell carcinoma (MCC) through a systematic review and meta-analysis. Methods: The PubMed, Cochrane database, and EMBASE database, from January 1990 to January 31, 2022, were searched for studies evaluating diagnostic performance of 18F-FDG PET or PET/CT for MCC. We determined the sensitivities and specificities across studies, calculated positive and negative likelihood ratios (LR+ and LR−), and constructed summary receiver operating characteristic curves. Results: Across 9 studies (259 patients), the pooled sensitivity of 18F-FDG PET or PET/CT was 0.91 (95% confidence interval [CI], 0.85–0.95) and a pooled specificity of 0.93 (95% CI, 0.86–0.97). Likelihood ratio syntheses gave an overall LR+ of 14.0 (95% CI, 6.6–29.6) and LR− of 0.09 (95% CI, 0.05–0.17). The pooled diagnostic odds ratio was 153 (95% CI, 57–416). Conclusion: 18F-FDG PET/CT showed an excellent performance for diagnosis of MCC. The likelihood ratio scattergram indicated that 18F-FDG PET or PET/CT is useful for exclusion and confirmation of MCC. Further large multicenter studies would be necessary to substantiate the diagnostic accuracy of 18F-FDG PET or PET/CT for MCC patients.

This publication has 30 references indexed in Scilit: